AI Identifies New Multiple Sclerosis Subtypes from Brain Scans
Researchers say the findings will help to identify those individuals with MS who are more likely to have disease progression.
Researchers say the findings will help to identify those individuals with MS who are more likely to have disease progression.
In vitro-transcribed mRNAs have been proven efficient in various therapeutic applications. However, manufacturing them poses challenges due in part to complexity of the molecules as…
Enzymes from gut bacteria open a new path to universal donor blood by efficiently clearing glycans from red blood cells.
Tumors of epigenetic, not genetic, origin have been demonstrated, challenging the established idea that cancer is caused only by permanent changes to DNA
Addition of B. subtilis spores also pushed mechanical properties of plastic beyond known limitations, addressing trade off between tensile strength and stretchability
The BEQVEZ gene therapy inserts a working copy of the Factor IX (FIX) gene that codes for a high-activity FIX variant.
Prime Medicine said it has gained FDA clearance for the first human trials of a prime editing therapy as the agency has approved an investigational…
What we know so far about the H5N1 influenza strain, otherwise known as “bird flu” or “avian flu,” and its spread in the United States.
While humanized animalmodels are relatively new to drug development compared to their non-humanizedcounterparts, they are critical tools in the landscape of biologic drugdevelopment. Their success…
A new study shows that an inhibitor called ESI1 could potentially treat multiple sclerosis and other conditions associated with demyelination.
A team of researchers sought to determine the efficacy of psilocybin as an antidepressant compared with placebo or non-psychoactive drugs.